Every contract development and manufacturing organization (CDMO) project starts with a technical transfer (“tech transfer”), the fundamental goal of which is to implement a process in a different place.

Use of CDMO organizations is influenced by facility availability, Good Manufacturing Practice (GMP) compliance, or production economics. Sometimes, a biopharmaceutical company lacks the capability, capacity, or technical expertise to take that next production step. Building such capability can be prohibitively expensive for smaller companies, while larger companies may simply have other plans for strategic utilization of their internal resources.

READ MORE BY FILLING OUT THE FORM >>>>>